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service users involved in research in England. Most of 
these were involved in the MHRN.
All is not well in the arena of service user involvement 
in health research, and especially mental health 
research in England. The ﬁ rst reason for this is that 
the topic-speciﬁ c networks, including the MHRN, 
have been dissolved into regional comprehensive 
networks with diluted patient involvement. The 800 
people referred to above no longer have a coherent 
voice. Secondly, there are also changes in mission, not 
exclusive to mental health, which indicate that the 
landscape is changing. INVOLVE was previously very 
clear in its objective to promote research by the public 
and not on them (that is, what research usually does). 
But its most recent document9 completely conﬂ ates 
involvement, engagement, and participation in the 
sense of recruitment. Of course, research cannot happen 
unless there are participants, and so recruitment is 
very important. But that is no excuse to pretend that 
recruitment means the same as involvement. To 
conﬂ ate the two is likely to substantially undermine user 
involvement in research as it has been understood for 
20 years, especially in mental health.
So is there a solution? Funding bodies in the English 
NHS still want to see evidence of patient and public 
involvement in research, although what this means may 
alter with the changes in ideology referred to here. For 
service user research in mental health, we will not give 
up without trying to protect hard won gains. Various 
university departments employ service user researchers, 
some in very senior positions. NGOs are active, along 
with a critical sector of independent researchers, some 
of whom were, like me, witness to the events of 1996. 
Some of these people are social scientists and historians 
who wish to go beyond and disrupt what has been 
accomplished so far in England, and this is a global 
phenomenon.10 The aim is to sustain the kind of activity 
supported by the MHRN, while opening doors to new 
and challenging thinking.
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Join us at The Lancet Clinic
On Oct 5, 2015, we launch the ﬁ rst 45 disease-speciﬁ c 
pages of a major new online initiative involving all Lancet 
journals that will bring together an overview Seminar 
and relevant Reviews, Clinical Series, Commissions, 
research, Case Reports, and Clinical Pictures. Over the 
next 18 months or so when The Lancet Clinic is complete, 
there will be online pages for 135 diseases, which we 
have identiﬁ ed by a combination of global burden of 
disease data and clinical practice needs. We hope that 
The Lancet Clinic will help practising doctors make better 
informed decisions that ultimately lead to better lives of 
people worldwide, and help others who want to educate 
or update themselves keep abreast of the evolving 
evidence base. Importantly, these pages will be updated 
at regular intervals. The authors of newly commissioned 
Seminars have agreed to provide regular summaries of 
important new evidence for 4 years. Individual clinical 
editors will pull together newly published material from 
across the Lancet journals and post links to these on the 
page regularly.
In addition, we are continuing our regular editorial 
policies of commissioning more specialised Clinical 
Reviews and Series across The Lancet Group to 





For The Lancet Clinic see 
http://www.thelancet.com/clinic
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in using this science for actual change. Commissions 
and Campaigns will be part of the disease pages to 
encourage engagement and actions. The Lancet Clinic 
invites you to be part of this endeavour.
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for key diseases. And beyond providing knowledge 
and information, we want to encourage academic 
and practising clinicians to use this knowledge for 
advocacy and change. In 2014, The Lancet published 
the ﬁ rst Clinical Commission on liver disease in the 
UK and in February, 2015, we launched our ﬁ rst 
Clinical Campaign based on this Commission. A 
Cancer Campaign as a joint eﬀ ort between The Lancet 
and The Lancet Oncology followed in April. Clinical 
Campaigns aim to eﬀ ect change based on data, 
knowledge, and expert interpretation in partnership 
with others. Further Clinical Commissions on asthma, 
hyper tension, dementia, tuberculosis, traumatic 
brain injury, psychotherapy, chronic obstructive pul-
monary disease, and others are underway across all 
Lancet journals. With these Clinical Commissions and 
Campaigns, we hope to extend our goal to publish the 
best science for better lives to being an active partner 
Corrections
Pirkis J, Too LS, Spittal MJ, et al. Interventions to reduce suicides at suicide 
hotspots: a systematic review and meta-analysis. Lancet Psychiatry 2015; 
2: 994–1001—In ﬁ gure 2 of this Article, a ‘0’ has been added to the top 
right circle of the image. In ﬁ gure 3, the incidence rate ratio (log) axis has 
now been presented to three decimal places to distinguish between 0·000 
and 0·002. These corrections have been made to the printed Article, and to 
the online version as of Oct 28, 2015.
